4th Quarter - Termination

BRAEBURN INC. FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC for BRAEBURN INC FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC

Period 4th Quarter 2021 Filed Jan 6, 2022 Signed by Edward Buckley

Official filing
Firm
BRAEBURN INC. FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC
Client
BRAEBURN INC FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC
Income
—
Expenses
$90,000
Expense method
A: Lobbying Disclosure Act definitions
Terminated
Dec 31, 2021

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 6, 2022 $90,000 Replaced
4th Quarter - Termination (this page) Jan 6, 2022 $90,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

HR 1629, S250 Fairness in Orphan Drug Exclusivity Act; Administration of controlled substances by HCPs; Storage of controlled substances HR 5950 - Improving Patient Access to Care and Treatment Act S. 3257 - To amend the Controlled Substances Act to lengthen the period of time during which certain controlled substances must be administered to a patient after being delivered by a pharmacy to the administering practitioner.

LobbyistCovered position, as disclosed
EDWARD BUCKLEY —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1629 (117th), H.R. 5950 (117th), S. 3257 (117th)

Health Issues HCR

HR 1629, S250 Fairness in Orphan Drug Exclusivity Act; Administration of controlled substances by HCPs; Storage of controlled substances HR 5950 - Improving Patient Access to Care and Treatment Act S. 3257 - To amend the Controlled Substances Act to lengthen the period of time during which certain controlled substances must be administered to a patient after being delivered by a pharmacy to the administering practitioner.

LobbyistCovered position, as disclosed
EDWARD BUCKLEY —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Bills named: H.R. 1629 (117th), S. 3257 (117th), H.R. 5950 (117th)

Medicare/Medicaid MMM

HR 1629, S250 Fairness in Orphan Drug Exclusivity Act; Administration of controlled substances by HCPs; Storage of controlled substances HR 5950 - Improving Patient Access to Care and Treatment Act S. 3257 - To amend the Controlled Substances Act to lengthen the period of time during which certain controlled substances must be administered to a patient after being delivered by a pharmacy to the administering practitioner.

LobbyistCovered position, as disclosed
EDWARD BUCKLEY —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Bills named: H.R. 1629 (117th), S. 3257 (117th), H.R. 5950 (117th)

Insurance INS

HR 1629, S250 Fairness in Orphan Drug Exclusivity Act; Administration of controlled substances by HCPs; Storage of controlled substances HR 5950 - Improving Patient Access to Care and Treatment Act S. 3257 - To amend the Controlled Substances Act to lengthen the period of time during which certain controlled substances must be administered to a patient after being delivered by a pharmacy to the administering practitioner.

LobbyistCovered position, as disclosed
EDWARD BUCKLEY —

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3257 (117th), H.R. 1629 (117th), H.R. 5950 (117th)

Pharmacy PHA

HR 1629, S250 Fairness in Orphan Drug Exclusivity Act; Administration of controlled substances by HCPs; Storage of controlled substances HR 5950 - Improving Patient Access to Care and Treatment Act S. 3257 - To amend the Controlled Substances Act to lengthen the period of time during which certain controlled substances must be administered to a patient after being delivered by a pharmacy to the administering practitioner.

LobbyistCovered position, as disclosed
EDWARD BUCKLEY —

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5950 (117th), S. 3257 (117th), H.R. 1629 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.